Invictus MD Strategies Corp (OTCMKTS: IVITF) has been making a huge move up in recent days exploding up the charts and transforming into a volume leader. The Company has had a September to remember and quickly attracted a large shareholder base who is bidding this one higher.
Invictus is quickly making a name for itself in the booming cannabis space responsible for many, many huge recent winners. The sector is on fire as we near legal recreational cannabis in Canada on October 17. According to a recent report from Deloitte provided to The Toronto Star recreational cannabis in Canada could be a $22.6 billion industry.
Invictus MD Strategies Corp (TSXV: GENE) (OTCQX: IVITF) (FRA: 8IS1) is a global cannabis company offering a selection of products under a wide range of lifestyle brands. The Company’s integrated sales approach is defined by five pillars of distribution including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores. The Company boast includes KISS music legend and business mogul Gene Simmons as Chief Evangelist Officer.
Invictus operates two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with 200,000 expected by January 2019 and 1 million by end of 2020. Invictus offers a diversified product portfolio with over 69 Health Canada approved strains that will be sold under four lifestyle-inspired cannabis brands for recreational users: Dukes, Zooey, Sterling & Hunt, and Sinister. Invictus employs a multifaceted distribution strategy including medical, recreational, international and retail.
Invictus product portfolio includes 69 Health Canada approved strains that will be sold under four lifestyle-inspired cannabis brands for recreational users: Dukes, Zooey, Sterling & Hunt, and Sinister. Each brand has been crafted for a specific target audience and his or her lifestyle.
In August Invictus secured a $25.5 million debt financing arrangement with ATB Financial to accelerate the construction of its Phase 3 and Phase 4 cannabis cultivation facilities at Acreage Pharms Ltd. located in West-Central Alberta. The Expansion Plan will add a total of 180,000 square feet of production capacity to Acreage Pharms. The Phase 3 expansion is underway with over $3 million in progress payments already made for permitting, lot preparation, foundation construction and precast installation. Phase 3 has a target completion date of January 2019 and will bring the Company’s gross cultivation space to 200,000 square feet. Phase 4 will be completed by mid-2019.
To Find out the inside Scoop on Invictus Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Earlier this year Invictus wholly-owned subsidiary, Acreage Pharms Ltd. has been granted conditional approval to become a registered supplier with the Saskatchewan Liquor and Gaming Authority once legislation is implemented on October 17, 2018. In the interim, and subject to any federal restrictions, Acreage Pharms is eligible to supply product to authorized provincial wholesalers and retailers in advance of October 17.
Invictus is set to gain access to the retail market in Saskatchewan through an LOI with GTEC Holdings Ltd. that provides the Company with an opportunity to fill purchase orders that GTEC is seeking from third party licensed producers for the purposes of supporting GTECs distribution channels.
In September the Company completed its first shipment of recreational cannabis under Provincial supply agreement on schedule, ensuring quality product for opening day on October 17, 2018. Staff have been working 24 hours per day, seven days a week to package product in order to meet this ambitious deadline.
To date, Invictus’ wholly-owned subsidiary Acreage Pharms has secured provincial supply agreements for the upcoming adult recreational markets in both British Columbia and Alberta, while actively pursuing supply agreements in other provinces. Invictus products will be sold under four lifestyle-inspired cannabis brands for recreational users: Dukes, Zooey, Sterling & Hunt, and Sinister.
On September 24 Invictus announced an update on its progress towards European Union Good Manufacturing Practices certification. Invictus’ wholly-owned subsidiary, Acreage Pharms Ltd. has designed and is currently building its Phase 3 and 4 purpose-built cultivation facilities to be EU-GMP compliant. EU-GMP standards are the most stringent regulations in the world and our team at Acreage Pharms are working together with professional consultants in both Canada and Germany to meet these standards.
The 90,000 square foot Phase 3 facility has an expected completion date of January 2019 and is fully funded as a result of the previously announced $25.5 million loan from ATB Financial. Approximately $10 million has been dedicated to the 90,000 square foot Phase 4 facility, which will commence construction upon completion of Phase 3.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $153 million market valuation Invictus is fully funded moving forward having previously announced $25.5 million loan from ATB Financial. The Company has virtually no debt and fast growing sales reporting $559,123 in revenues for the three months ended July 31, 2018 up from $395,989 for the same period last year. Invictus is on exciting cannabis play well positioned to cash in on the Canadian cannabis craze; the Company operates two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with 200,000 expected by January 2019 and 1 million by end of 2020. We will be updating on Invictus when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Invictus.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in Invictus either long or short and we have not been compensated for this article.